Vahaticor, Inc.
Clinical trials sponsored by Vahaticor, Inc., explained in plain language.
-
New device offers hope for chest pain sufferers with Hard-to-Treat heart condition
Symptom relief Recruiting nowThis early study tests a device called the A-FLUX Reducer, placed in a heart vein to improve blood flow and reduce chest pain in people with coronary microvascular dysfunction (CMD). About 30 adults with persistent symptoms despite standard treatments will take part. The goal is …
Phase: NA • Sponsor: VahatiCor, Inc. • Aim: Symptom relief
Last updated May 26, 2026 03:41 UTC
-
New device aims to ease stubborn chest pain in heart disease patients
Symptom relief Recruiting nowThis early study tests a new device called the A-FLUX Reducer for people with chest pain caused by small heart vessel disease (microvascular dysfunction). The device is placed in a vein near the heart to improve blood flow and reduce symptoms. About 30 adults with persistent ches…
Phase: NA • Sponsor: VahatiCor, Inc. • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC